Top

Published in:

Open Access 01-12-2018 | Short communication

Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo

Authors: Emiko Desvaux, Alan Courteau, Pierre-Simon Bellaye, Mélanie Guillemin, Camille Drouet, Paul Walker, Bertrand Collin, Richard A. Decréau

Published in: EJNMMI Research | Issue 1/2018

Abstract

Purpose

Molecular imaging techniques visualise biomarkers for both drug development and personalised medicine. In this field, Cherenkov luminescence imaging (CLI) seems to be very attractive by allowing imaging with clinical PET radiotracers with high-throughput capabilities. In this context, we developed a fast CLI method to detect tumour hypoxia with ¹⁸F-fluoromisonidazole (FMISO) for drug development purposes.

Methods

Colon cancer model was induced in mice by subcutaneous injection of 1 × 10⁶ CT-26 cells. FMISO was injected, and simultaneous PET-blood oxygen level dependent (BOLD)-MRI followed by CLI were performed along with immunohistochemistry staining with pimonidazole.

Results

There was a significant correlation between FMISO PET and CLI tumour uptakes, consistent with the BOLD-MRI mapping. Tumour-to-background ratio was significantly higher for CLI compared with PET and MRI. Immunohistochemistry confirmed tumour hypoxia. The imaging workflow with CLI was about eight times faster than the PET-MRI procedure.

Conclusion

CLI is a fast and relevant tool to assess tumour hypoxia. This approach could be particularly interesting for hypoxia-targeting drug development.

Available only for authorised users

Cunha L, Szigeti K, Mathe D, Metello LF. The role of molecular imaging in modern drug development. Drug Discov Today. 2014;19:936–48. https://doi.org/10.1016/j.drudis.2014.01.003.CrossRefPubMed

Ciarrocchi E, Belcari N. Cerenkov luminescence imaging: physics principles and potential applications in biomedical sciences. EJNMMI Phys. 2017;4:14. https://doi.org/10.1186/s40658-017-0181-8.CrossRefPubMedPubMedCentral

Fleming IN, Manavaki R, Blower PJ, West C, Williams KJ, Harris AL, et al. Imaging tumour hypoxia with positron emission tomography. Br J Cancer. 2015;112:238–50. https://doi.org/10.1038/bjc.2014.610.CrossRefPubMed

Judenhofer MS, Cherry SR. Applications for preclinical PET/MRI. Semin Nucl Med. 2013;43:19–29. https://doi.org/10.1053/j.semnuclmed.2012.08.004.CrossRefPubMed

Grkovski M, Fanchon L, Pillarsetty NVK, Russell J, Humm JL. (18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model. EJNMMI Res. 2018;8:53. https://doi.org/10.1186/s13550-018-0409-1.CrossRefPubMedPubMedCentral

Van Cutsem E, Verheul HM, Flamen P, Rougier P, Beets-Tan R, Glynne-Jones R, et al. Imaging in colorectal cancer: progress and challenges for the clinicians. Cancers. 2016;8. https://doi.org/10.3390/cancers8090081.

Thorek DL, Riedl CC, Grimm J. Clinical Cerenkov luminescence imaging of (18)F-FDG. J Nucl Med. 2014;55:95–8. https://doi.org/10.2967/jnumed.113.127266. CrossRefPubMed

Xu Y, Liu H, Cheng Z. Harnessing the power of radionuclides for optical imaging: Cerenkov luminescence imaging. J Nucl Med. 2011;52:2009–18. https://doi.org/10.2967/jnumed.111.092965.CrossRefPubMed

Maier FC, Schmitt J, Maurer A, Ehrlichmann W, Reischl G, Nikolaou K, et al. Correlation between positron emission tomography and Cerenkov luminescence imaging in vivo and ex vivo using 64Cu-labeled antibodies in a neuroblastoma mouse model. Oncotarget. 2016;7:67403–11. https://doi.org/10.18632/oncotarget.11795.CrossRefPubMedPubMedCentral

10.

Zhang X, Kuo C, Moore A, Ran C. In vivo optical imaging of interscapular brown adipose tissue with (18)F-FDG via Cerenkov luminescence imaging. PLoS One. 2013;8:e62007. https://doi.org/10.1371/journal.pone.0062007.CrossRefPubMedPubMedCentral

11.

Natarajan A, Habte F, Liu H, Sathirachinda A, Hu X, Cheng Z, et al. Evaluation of 89Zr-rituximab tracer by Cerenkov luminescence imaging and correlation with PET in a humanized transgenic mouse model to image NHL. Mol Imaging Biol. 2013;15:468–75. https://doi.org/10.1007/s11307-013-0624-0. CrossRefPubMed

12.

Bernhard Y, Collin B, Decreau RA. Redshifted Cherenkov radiation for in vivo imaging: coupling Cherenkov radiation energy transfer to multiple Forster resonance energy transfers. Sci Rep. 2017;7:45063. https://doi.org/10.1038/srep45063.CrossRefPubMedPubMedCentral

13.

Grootendorst MR, Cariati M, Kothari A, Tuch DS, Purushotham A. Cerenkov luminescence imaging (CLI) for image-guided cancer surgery. Clin Transl Imaging. 2016;4:353–66. https://doi.org/10.1007/s40336-016-0183-x.CrossRefPubMedPubMedCentral

14.

Lv PC, Roy J, Putt KS, Low PS. Evaluation of a carbonic anhydrase IX-targeted near-infrared dye for fluorescence-guided surgery of hypoxic tumors. Mol Pharm. 2016;13:1618–25. https://doi.org/10.1021/acs.molpharmaceut.6b00065.CrossRefPubMedPubMedCentral

15.

Chua BH, Kron T. Intraoperative radiotherapy with image guidance: mix and match. J Med Imaging Radiat Oncol. 2018. https://doi.org/10.1111/1754-9485.12836.

Title: Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo
Authors: Emiko Desvaux
Alan Courteau
Pierre-Simon Bellaye
Mélanie Guillemin
Camille Drouet
Paul Walker
Bertrand Collin
Richard A. Decréau
Publication date: 01-12-2018
Publisher: Springer Berlin Heidelberg
Published in: EJNMMI Research / Issue 1/2018
Electronic ISSN: 2191-219X
DOI: https://doi.org/10.1186/s13550-018-0464-7

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2018

PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma

The value of 99mTc-MAA SPECT/CT for lung shunt estimation in 90Y radioembolization: a phantom and patient study

Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [177Lu-[DOTA0, Tyr3]-octreotate

Volume-of-interest-based supervised cluster analysis for pseudo-reference region selection in [18F]DPA-714 PET imaging of the rat brain

Monitoring scanner calibration using the image-derived arterial blood SUV in whole-body FDG-PET

Optimization of temporal sampling for 18F-choline uptake quantification in prostate cancer assessment